Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland.


Journal

Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869

Informations de publication

Date de publication:
01 2021
Historique:
received: 23 06 2020
accepted: 20 11 2020
entrez: 22 12 2020
pubmed: 23 12 2020
medline: 14 1 2021
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) was first diagnosed in Scotland on 1 March 2020. During the first month of the outbreak, 2,641 cases of COVID-19 led to 1,832 hospital admissions, 207 intensive care admissions and 126 deaths. We aimed to identify the source and number of introductions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into Scotland using a combined phylogenetic and epidemiological approach. Sequencing of 1,314 SARS-CoV-2 viral genomes from available patient samples enabled us to estimate that SARS-CoV-2 was introduced to Scotland on at least 283 occasions during February and March 2020. Epidemiological analysis confirmed that early introductions of SARS-CoV-2 originated from mainland Europe (the majority from Italy and Spain). We identified subsequent early outbreaks in the community, within healthcare facilities and at an international conference. Community transmission occurred after 2 March, 3 weeks before control measures were introduced. Earlier travel restrictions or quarantine measures, both locally and internationally, would have reduced the number of COVID-19 cases in Scotland. The risk of multiple reintroduction events in future waves of infection remains high in the absence of population immunity.

Identifiants

pubmed: 33349681
doi: 10.1038/s41564-020-00838-z
pii: 10.1038/s41564-020-00838-z
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112-122

Subventions

Organisme : Wellcome Trust
ID : 201492/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19026
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L015080/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204802/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19027
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206298/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12014/10
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn
Type : ErratumIn

Références

Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265–269 (2020).
doi: 10.1038/s41586-020-2008-3
Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
doi: 10.1038/s41586-020-2012-7
Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
doi: 10.1056/NEJMoa2001017
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536–544 (2020).
Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).
doi: 10.1016/S0140-6736(20)30183-5
Mao, L. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77, 683–690 (2020).
doi: 10.1001/jamaneurol.2020.1127
Verdoni, L. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 395, 1771–1778 (2020).
doi: 10.1016/S0140-6736(20)31103-X
Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV) (World Health Organization, 2020).
WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020 (World Health Organization, 2020).
Quick, J. et al. Real-time, portable genome sequencing for Ebola surveillance. Nature 530, 228–232 (2016).
doi: 10.1038/nature16996
Grubaugh, N. D. et al. Genomic epidemiology reveals multiple introductions of Zika virus into the United States. Nature 546, 401–405 (2017).
doi: 10.1038/nature22400
Grubaugh, N. D. et al. Tracking virus outbreaks in the twenty-first century. Nat. Microbiol. 4, 10–19 (2019).
doi: 10.1038/s41564-018-0296-2
Kafetzopoulou, L. E. et al. Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak. Science 363, 74–77 (2019).
doi: 10.1126/science.aau9343
Biek, R., Pybus, O. G., Lloyd-Smith, J. O. & Didelot, X. Measurably evolving pathogens in the genomic era. Trends Ecol. Evol. 30, 306–313 (2015).
doi: 10.1016/j.tree.2015.03.009
Hill, K. J. et al. The index case of SARS-CoV-2 in Scotland. J. Infect. 81, 147–178 (2020).
doi: 10.1016/j.jinf.2020.03.022
Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 5, 1403–1407 (2020).
doi: 10.1038/s41564-020-0770-5
Korber, B. et al. Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell 182, 812–827 (2020).
doi: 10.1016/j.cell.2020.06.043
Tong, Z. D. et al. Potential presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerg. Infect. Dis. 26, 1052–1054 (2020).
doi: 10.3201/eid2605.200198
Pung, R. et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet 395, 1039–1046 (2020).
doi: 10.1016/S0140-6736(20)30528-6
Thompson, C. P. et al. Detection of neutralising antibodies to SARS coronavirus 2 to determine population exposure in Scottish blood donors between March and May 2020. Euro Surveill. 25, 2000685 (2020).
doi: 10.2807/1560-7917.ES.2020.25.42.2000685
Foreign Office Advises Against All but Essential Travel to China (Foreign and Commonwealth Office, 2020); https://www.gov.uk/government/news/fco-advises-against-all-but-essential-travel-to-mainland-china
Preparations for Coronavirus Stepped Up (Scottish Government, 2020); https://www.gov.scot/news/preparations-for-coronavirus-stepped-up
Communicable Disease Threats Report; 16–22 February 2020, Week 8 (European Centre for Disease Prevention and Control, 2020).
Outbreak of Novel Coronavirus Disease 2019 (COVID19): Situation in Italy—23 February 2020 (European Centre for Disease Prevention and Control, 2020).
The COVID-19 Genomics UK (COG-UK) Consortium. An integrated national scale SARS-CoV-2 genomic surveillance network. Lancet Microbe 1, e99–e100 (2020).
doi: 10.1016/S2666-5247(20)30054-9
Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 25, 2000045 (2020).
pubmed: 6988269 pmcid: 6988269
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
doi: 10.1093/bioinformatics/btp324
Grubaugh, N. D. et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 20, 8 (2019).
doi: 10.1186/s13059-018-1618-7
Stubbs, S. C. B. et al. Assessment of a multiplex PCR and nanopore-based method for dengue virus sequencing in Indonesia. Virol. J. 17, 24 (2020).
doi: 10.1186/s12985-020-1294-6
Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2—approximately maximum-likelihood trees for large alignments. PLoS ONE 5, e9490 (2010).
doi: 10.1371/journal.pone.0009490
Farris, J. S. Methods for computing Wagner trees. Syst. Zool. 19, 83–92 (1970).
doi: 10.2307/2412028
Sagulenko, P., Puller, V. & Neher, R. A. TreeTime: maximum-likelihood phylodynamic analysis. Virus Evol. 4, vex042 (2018).
doi: 10.1093/ve/vex042

Auteurs

Ana da Silva Filipe (A)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

James G Shepherd (JG)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Thomas Williams (T)

MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Joseph Hughes (J)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Elihu Aranday-Cortes (E)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Patawee Asamaphan (P)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Shirin Ashraf (S)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Carlos Balcazar (C)

Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.

Kirstyn Brunker (K)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Alasdair Campbell (A)

Royal Hospital for Children and Young People, Edinburgh, UK.

Stephen Carmichael (S)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Chris Davis (C)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Rebecca Dewar (R)

Virology Department, Royal Infirmary of Edinburgh, Edinburgh, UK.

Michael D Gallagher (MD)

The Roslin Institute, University of Edinburgh, Edinburgh, UK.

Rory Gunson (R)

West of Scotland Specialist Virology Centre, Glasgow Royal Infirmary, Glasgow, UK.
Institute of Infection Immunity and Inflammation, University of Glasgow, Glasgow, UK.

Verity Hill (V)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK.

Antonia Ho (A)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Ben Jackson (B)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK.

Edward James (E)

Borders General Hospital, Melrose, UK.

Natasha Jesudason (N)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Natasha Johnson (N)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

E Carol McWilliam Leitch (EC)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Kathy Li (K)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Alasdair MacLean (A)

West of Scotland Specialist Virology Centre, Glasgow Royal Infirmary, Glasgow, UK.

Daniel Mair (D)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

David A McAllister (DA)

Public Health Scotland, Glasgow, UK.
Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

John T McCrone (JT)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK.

Sarah E McDonald (SE)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Martin P McHugh (MP)

Virology Department, Royal Infirmary of Edinburgh, Edinburgh, UK.
School of Medicine, University of St Andrews, St Andrews, UK.

A Keith Morris (AK)

Victoria Hospital, Kirkcaldy, UK.

Jenna Nichols (J)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Marc Niebel (M)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Kyriaki Nomikou (K)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Richard J Orton (RJ)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Áine O'Toole (Á)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK.

Massimo Palmarini (M)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Benjamin J Parcell (BJ)

Ninewells Hospital and Medical School, Dundee, UK.

Yasmin A Parr (YA)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Andrew Rambaut (A)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK.

Stefan Rooke (S)

Institute of Infection Immunity and Inflammation, University of Glasgow, Glasgow, UK.

Sharif Shaaban (S)

Public Health Scotland, Glasgow, UK.

Rajiv Shah (R)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Joshua B Singer (JB)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Katherine Smollett (K)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Igor Starinskij (I)

West of Scotland Specialist Virology Centre, Glasgow Royal Infirmary, Glasgow, UK.

Lily Tong (L)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Vattipally B Sreenu (VB)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Elizabeth Wastnedge (E)

Virology Department, Royal Infirmary of Edinburgh, Edinburgh, UK.

Matthew T G Holden (MTG)

Public Health Scotland, Glasgow, UK.
School of Medicine, University of St Andrews, St Andrews, UK.

David L Robertson (DL)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK.

Kate Templeton (K)

Virology Department, Royal Infirmary of Edinburgh, Edinburgh, UK.

Emma C Thomson (EC)

MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, UK. emma.thomson@glasgow.ac.uk.
Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK. emma.thomson@glasgow.ac.uk.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH